EUR A Copycat: Europe's New US-style Clearing Model

The FIA has announced the development of a new European Agent Trustee Model (EATM) for client clearing of OTC derivative transactions.
Worldwide Finance and Banking
To print this article, all you need is to be registered or login on Mondaq.com.

The FIA has announced the development of a new European Agent Trustee Model (EATM) for client clearing of OTC derivative transactions.

This model broadly mirrors the US-style agency model, under which a trading fund is a client of a central counterparty/clearing house (CCP), but a clearing member (i.e. a clearing broker, referred to as a ‘Futures Commission Merchant') acts as agent on behalf of the fund. The new model has been developed in conjunction with clearing members and European CCPs.

The EATM is designed to complement, rather than substitute, the existing ‘principal' model in Europe under which the fund has a direct relationship with a clearing broker (the client leg), which in turn contracts with the CCP and enters into transactions matching, but opposite to, those under the client leg.

The new model results in the same commercial position for participants, but with a trustee arrangement replacing the back-to-back transactions under the principal model. Instead, the fund gains a beneficial interest in the transactions entered into by the clearing broker as trustee i.e., the claims that the clearing broker has against the CCP. Another key difference is that under the EATM, collateral and payments made by the fund are passed onto the clearing broker under a title transfer collateral arrangement and will not be subject to any applicable client money/client asset rules. 

The FIA has developed an English model, under which the clearing broker holds transactions on behalf of a fund as bare trustee, and a German model, under which the clearing broker acts as a trustee with a commercial mandate. The FIA is willing to consider models for other jurisdictions (which are driven by the jurisdiction of CCPs) depending on interest from market participants. The initial scope of EATM will be directly cleared OTC derivatives.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More